UPDATE: Goldman Sachs Upgrades Teva Pharmaceutical Industries

By: via Benzinga
Goldman Sachs on Wednesday upgraded shares of Teva Pharmaceutical Industries (NYSE: TEVA) from Sell to Neutral and raised the price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.